Cheaper Breast Cancer Drug Does Well in Clinical Trial - U.S. News & World Report

U.S. News & World Report

Cheaper Breast Cancer Drug Does Well in Clinical Trial U.S. News & World Report FRIDAY, June 3, 2016 (HealthDay News) -- For women with advanced HER2-positive breast cancer, a similar but less expensive experimental drug works just as well as the standard drug Herceptin (trastuzumab), a new study finds. HER2-positive tumors ... Copycat biotech cancer drug works as well as Roche original: studyReuters Biosimilar Trastuzumab Shines in Phase III TrialClinical Oncology News 'Comparable' Efficacy and Safety for Trastuzumab BiosimilarMedscape FierceBiotech -Wall Street Journal -Economic Times -OncLive all 38 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNGdkU_luplFbwLAwp8bDdoVuzT83A&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779126286493&ei=rr9UV9jNIo7N3gGrqIigDg&url=http://health.usnews.com/health-care/articles/2016-06-03/cheaper-breast-cancer-drug-does-well-in-clinical-trial
via IFTTT